Cargando…
Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma
Autores principales: | Chen, Mark, Kirsch, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510721/ https://www.ncbi.nlm.nih.gov/pubmed/31143874 http://dx.doi.org/10.1016/j.eclinm.2019.03.015 |
Ejemplares similares
-
Tumor Calcification: A New Response Pattern of Myxoid Liposarcoma to Trabectedin
por: Turpin, Anthony, et al.
Publicado: (2014) -
Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma
por: Tamiya, Hironari, et al.
Publicado: (2020) -
Trabectedin as second-line treatment in metastatic myxoid liposarcoma: a case report
por: Pedrinaci, Irene Zarcos, et al.
Publicado: (2012) -
Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
por: Bello, Ezia, et al.
Publicado: (2019) -
Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
por: Bello, Ezia, et al.
Publicado: (2020)